<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">19806373</PMID>
<DateCompleted>
<Year>2010</Year>
<Month>07</Month>
<Day>15</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1364-6753</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>11</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2010</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Neurogenetics</Title>
<ISOAbbreviation>Neurogenetics</ISOAbbreviation>
</Journal>
<ArticleTitle>Revisiting the phenotype associated with FOXG1 mutations: two novel cases of congenital Rett variant.</ArticleTitle>
<Pagination>
<MedlinePgn>241-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s10048-009-0220-2</ELocationID>
<Abstract>
<AbstractText>The Forkhead box G1 (FOXG1) is a transcription factor that is critical for forebrain development, where it promotes progenitor proliferation and suppresses premature neurogenesis. Recently, the FOXG1 gene was implicated in the molecular aetiology of the congenital variant of Rett syndrome. So far, 15 FOXG1 molecular alterations, including only eight point mutations, have been reported. We screened the FOXG1 gene in a cohort of 206 MECP2 and CDKL5 mutation negative patients (136 females and 70 males) with severe encephalopathy and microcephaly. The screening was negative in all males, but two de novo mutations (c.1248C&gt;G, p.Y416X and c.460_461dupG, p.E154GfsX300) were identified in two unrelated girls. Both patients showed neurological symptoms from the neonatal period with poor reactivity, hypotonia, and severe microcephaly. During the first year of life, both patients had feeding difficulties and made slow developmental progress. At 5 years old, the girls were significantly neurologically impaired with gross hypotonia, no language, convergent strabismus, and no voluntary hand use. Moreover, they presented a combination of jerky movements, hand-mouthing, and hand-washing stereotypies. Hence, FOXG1 mutation patients demonstrate severe encephalopathy compatible with the congenital variant, as well as additional features such as absent eye contact, inconsolable crying during the perinatal period, and delayed myelination with thin to hypoplastic corpus callosum. Although the overall frequency of mutations in FOXG1 in females with severe mental retardation and microcephaly appears to be low (1.5%), our findings suggest the requirement to investigate both point mutations and gene dosage in the FOXG1 gene in patients with severe encephalopathy with microcephaly and some Rett-like features.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bahi-Buisson</LastName>
<ForeName>Nadia</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Universit√© Paris Descartes, Institut Cochin, CNRS (UMR8104), Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nectoux</LastName>
<ForeName>Juliette</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Girard</LastName>
<ForeName>Benoit</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Van Esch</LastName>
<ForeName>Hilde</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>De Ravel</LastName>
<ForeName>Thomy</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Boddaert</LastName>
<ForeName>Nathalie</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Plouin</LastName>
<ForeName>Perrine</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rio</LastName>
<ForeName>Marlene</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fichou</LastName>
<ForeName>Yann</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chelly</LastName>
<ForeName>Jamel</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bienvenu</LastName>
<ForeName>Thierry</ForeName>
<Initials>T</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2009</Year>
<Month>10</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Neurogenetics</MedlineTA>
<NlmUniqueID>9709714</NlmUniqueID>
<ISSNLinking>1364-6745</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C090173">FOXG1 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051858">Forkhead Transcription Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C497392">MECP2 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051783">Methyl-CpG-Binding Protein 2</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004252">DNA Mutational Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004569">Electroencephalography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051858">Forkhead Transcription Factors</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051783">Methyl-CpG-Binding Protein 2</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D009154">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009419">Nerve Tissue Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D010641">Phenotype</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011247">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015518">Rett Syndrome</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2009</Year>
<Month>05</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2009</Year>
<Month>09</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2009</Year>
<Month>10</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2009</Year>
<Month>10</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2010</Year>
<Month>7</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">19806373</ArticleId>
<ArticleId IdType="doi">10.1007/s10048-009-0220-2</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Neurology. 2007 Apr 10;68(15):1183-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17420401</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Neurol. 1994 Jul;11(1):5-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7986294</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Med Genet A. 2008 Aug 1;146A(15):1994-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18627055</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Med Genet A. 2003 Oct 15;122A(3):227-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12966523</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Dev. 2001 Dec;23 Suppl 1:S251-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11738885</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Genet. 2010 Jan;47(1):49-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19578037</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Hum Genet. 2008 Jul;83(1):89-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18571142</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Mol Genet. 2000 May 22;9(9):1369-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10814718</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuropediatrics. 1995 Apr;26(2):62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7566453</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Med Genet. 2009 Mar-Jun;52(2-3):148-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19303466</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Hum Genet. 2009 Dec;17(12):1577-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19623215</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Genet. 2010 Jan;47(1):59-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19564653</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Med Genet A. 2006 Oct 15;140(20):2180-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16955412</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Genet. 2005 Oct;117(6):536-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16133170</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain. 2008 Oct;131(Pt 10):2647-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18790821</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epilepsia. 2008 Jun;49(6):1027-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18266744</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>